Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
90,615,768
-
Share change
-
-2,358,843
-
Total reported value
-
$4,553,661,441
-
Put/Call ratio
-
130%
-
Price per share
-
$50.26
-
Number of holders
-
257
-
Value change
-
-$105,568,840
-
Number of buys
-
123
-
Number of sells
-
120
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q4 2020
As of 31 Dec 2020,
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) was held by
257 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,615,768 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, P2 Capital Partners, LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Bank of New York Mellon Corp, and STATE STREET CORP.
This page lists
258
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.